Unknown

Dataset Information

0

The perfect personalized cancer therapy: cancer vaccines against neoantigens.


ABSTRACT: In the advent of Immune Checkpoint inhibitors (ICI) and of CAR-T adoptive T-cells, the new frontier in Oncology is Cancer Immunotherapy because of its ability to provide long term clinical benefit in metastatic disease in several solid and liquid tumor types. It is now clear that ICI acts by unmasking preexisting immune responses as well as by inducing de novo responses against tumor neoantigens. Thanks to theprogress made in genomics technologies and the evolution of bioinformatics, neoantigens represent ideal targets, due to their specific expression in cancer tissue and the potential lack of side effects. In this review, we discuss the promise of preclinical and clinical results with mutation-derived neoantigen cancer vaccines (NCVs) along with the current limitations from bioinformatics prediction to manufacturing an effective new therapeutic approach.

SUBMITTER: Aurisicchio L 

PROVIDER: S-EPMC5910567 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

The perfect personalized cancer therapy: cancer vaccines against neoantigens.

Aurisicchio Luigi L   Pallocca Matteo M   Ciliberto Gennaro G   Palombo Fabio F  

Journal of experimental & clinical cancer research : CR 20180420 1


In the advent of Immune Checkpoint inhibitors (ICI) and of CAR-T adoptive T-cells, the new frontier in Oncology is Cancer Immunotherapy because of its ability to provide long term clinical benefit in metastatic disease in several solid and liquid tumor types. It is now clear that ICI acts by unmasking preexisting immune responses as well as by inducing de novo responses against tumor neoantigens. Thanks to theprogress made in genomics technologies and the evolution of bioinformatics, neoantigens  ...[more]

Similar Datasets

| S-EPMC5423853 | biostudies-literature
| S-EPMC6319136 | biostudies-literature
| S-EPMC7612664 | biostudies-literature
| S-EPMC10795827 | biostudies-literature
2023-12-11 | GSE244992 | GEO
| S-EPMC5448976 | biostudies-literature
2022-04-06 | PXD026463 | Pride
| S-EPMC6096398 | biostudies-literature
| EGAS00001003306 | EGA
| S-EPMC6508552 | biostudies-literature